Nektar Therapeutics
NKTR
#6053
Rank
A$1.56 B
Marketcap
A$45.63
Share price
-7.19%
Change (1 day)
-51.24%
Change (1 year)

Earnings for Nektar Therapeutics (NKTR)

Earnings in 2026 (TTM): -A$0.23 Billion

According to Nektar Therapeutics 's latest financial reports the company's current earnings are A$54.58 Million. In 2025 the company made an earning of -A$0.24 Billion a decrease over its 2024 earnings that were of -A$0.19 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nektar Therapeutics from 1994 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.23 Billion-4.07%
2025 -A$0.24 Billion30.44%
2024 -A$0.19 Billion-56.85%
2023 -A$0.42 Billion-24.31%
2022 -A$0.56 Billion-30.25%
2021 -A$0.8 Billion17.87%
2020 -A$0.68 Billion0.88%
2019 -A$0.67 Billion-164.46%
2018 A$1.03 B-810.61%
2017 -A$0.15 Billion-37.06%
2016 -A$0.24 Billion89.22%
2015 -A$0.13 Billion48.22%
2014 -A$82.23 Million-65.93%
2013 -A$0.25 Billion-6.81%
2012 -A$0.26 Billion28.95%
2011 -A$0.21 Billion258.8%
2010 -A$55.99 Million-63.94%
2009 -A$0.16 Billion-392.45%
2008 A$53.09 M-211.74%
2007 -A$47.52 Million-79.57%
2006 -A$0.24 Billion-16.9%
2005 -A$0.28 Billion81.53%
2004 -A$0.16 Billion54.19%
2003 -A$100 Million-33.87%
2002 -A$0.16 Billion-9.6%
2001 -A$0.17 Billion73.39%
2000 -A$96.47 Million108.9%
1999 -A$46.18 Million39.48%
1998 -A$33.11 Million60.02%
1997 -A$20.69 Million18.05%
1996 -A$17.53 Million31.82%
1995 -A$13.3 Million57.14%
1994 -A$8.47 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$28.28 B-12,326.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$10.52 B-4,650.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$16.69 B-7,318.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-A$0.29 Billion 22.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$10.15 B-4,490.85%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$22.79 B-9,954.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
A$15.4 M-106.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
A$0.26 B-214.07%๐Ÿ‡ฎ๐Ÿ‡ช Ireland